Back to Journals » Biologics: Targets and Therapy » Volume 12

Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection

Total article views   Abstract views HTML views PDF downloads Totals
8,430 Dovepress* 4,575 646+ 896 5,221
PubMed Central* 0 3,209 468 3,209
Totals 4,575 3,855 1,364 8,430
*Since 18 January 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
7 0 0 0 3 4

View citations on PubMed Central and Google Scholar